Sort
46,585 grants matching “heart failure”
Proteogenomics for Organ Transplantation: Prediction, Diagnosis, Intervention
$2,011,498Michael Abecassis · Northwestern University At Chicago · U01 · FY2012 · AI
REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)
$2,010,978Monika M Safford · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · HL
Main Administrative Core
$2,008,967Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2021 · AG
PumpKIN Preclinical Program
$2,007,320Janet Simons · University Of Maryland Baltimore · N01 · FY2010 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)
$2,007,149Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2025 · HL
NEURO-CIRCULATORY FUNCTION IN CHRONIC HEART DISEASE
$2,006,910University Of Nebraska Medical Center · P01 · FY2004 · HL
SPORE: Brain Tumore SPORE Grant
$2,006,093Mitchel S. Berger · University Of California, San Francisco · P50 · FY2016 · CA
COBRE in CV Health Administrative Core
$2,004,867David G Edwards · University Of Delaware · P20 · FY2019 · GM
THE ROLE OF TRANSGLUTAMINASE-2 (TG2) IN ISCHEMIC AND NON-ISCHMEIC HEART FAILURE
$2,004,000Albert Einstein College Of Medicine · · FY2019 · Department of the Army
Task Order One (1) shall encompass conduct of and support for core study operations, data analysis, manuscript preparation, and morbidity and mortality ascertainment. The Field Center shall contact su
$2,002,690Adolfo Correa · University Of Mississippi Med Ctr · N01 · FY2021 · HL
System Biology Center in New York
$2,000,001Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · GM
Long-acting PTH for hypoparathyroidism
$2,000,000Laura M Hales · Extend Biosciences, Inc. · R44 · FY2021 · DK
Warfarin vs. Aspirin in Reduced Ejection Fraction (WARCEF)
$2,000,000Shunichi Homma · Columbia University Health Sciences · U01 · FY2010 · NS
Biograph Vision 600 PET/CT system
$2,000,000Peter James Henry Scott · University Of Michigan At Ann Arbor · S10 · FY2023 · OD
Ensemble Density Analysis for Stochastic Models of Cardiac Excitation-Contraction Coupling
$2,000,000Mohsin S Jafri · George Mason University · · FY2005 · MPS
IGF::OT::IGF Topic 090, Phase II, Devices to Close Ductus Arteriosus in Premature Infants IGF::OT::IGF
$1,999,623Paul Lubock · · N44 · FY2017 · HL
Nonmyeloablative allogeneic PBSC in globin disorders
$1,999,033John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
$1,998,124Roham Zamanian · Stanford University · UG3 · FY2025 · HL
IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart
$1,997,399Pilar Ruiz-Lozano · Regencor, Inc. · R44 · FY2020 · HL
Development of a novel drug treatment for decompensated heart failure.
$1,996,767Lawrence Mahan · Madeleine Pharmaceuticals, Inc. · R44 · FY2016 · HL
Magscrew TAH Testing thru Pre-Clinical Readiness
$1,996,034Cleveland Clinic Foundation · R01 · FY2002 · HL
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY
$1,995,340University Of California San Diego · P01 · FY2002 · HL
Biology and Therapeutics of Cardiovascular Peptides
$1,994,515John C Burnett · Mayo Clinic Rochester · P01 · FY2006 · HL
The Delta Ecology of NSCLC Treatment
$1,992,935Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Gene Therapy for Lung and Cardiovascular Disease
$1,992,904University Of Florida · P01 · FY2004 · HL